Akebia Therapeutics Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 07:15PM GMT
Cindy Xu JPMorgan-Analyst

All right. Welcome, everyone. Welcome to the last day of JPMorgan Healthcare Conference in 2024. My name is Cindy Xu. I'm an associate with the JPMorgan healthcare investment banking team. It's my great pleasure today to introduce John Butler, the CEO of Akebia Therapeutics.

John Butler Akebia Therapeutics - Inc. - President & CEO

Cindy, thank you. Thank you very much. Thanks for the invitation to present today. I am fighting my voice a little bit after three-plus days of kind of nonstop meetings. But it's quite heartening to have all of the investor community so interested in hearing the Akebia story. So we'll get through the next 40 minutes or so.

But I just want to remind everyone I'm going to be making forward-looking statements. So please refer to our SEC filings for more information.

So I really am excited to talk to you about Akebia today and where we are. And I'm really proud to be here to represent the employees of Akebia, the Akebia team, who has put the company in such a really positive spot

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot